Canadian Journal of Gastroenterology and Hepatology / 2016 / Article / Tab 2 / Research Article
Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study Table 2 Fecal immunochemical test performance by test cut-off.
≥10 μ g/g (≥50 ng/mL) ( /%) ≥15 μ g/g (≥75 ng/mL) ( /%) ≥20 μ g/g (≥100 ng/mL) ( /%) ≥40 μ g/g (≥200 ng/mL) ( /%) ≥100 μ g/g (≥500 ng/mL) ( /%) CRC 449 (2.3) 409 (3.1) 388 (3.8) 344 (5.7) 242 (8.4) Missed CRC — 40 (8.9) 61 (13.6) 105 (23.4) 207 (46.1) HRA 4012 (20.4) 3176 (24.4) 2712 (26.9) 1911 (31.6) 1109 (38.4) Missed HRA — 836 (20.8) 1300 (32.4) 2101 (52.4) 2903 (72.4) MLRA 1173 (6.0) 772 (5.9) 584 (5.8) 321 (5.3) 132 (4.6) LRA 5029 (25.6) 3172 (24.4) 2359 (23.4) 1247 (20.6) 474 (16.4) All neoplasia 10663 (54.2) 7529 (57.8) 6043 (59.9) 3823 (63.2) 1957 (67.8) CSPY saved — 6641 (33.8) 9571 (48.7) 13615 (69.3) 16773 (85.3) Total results 19660 13019 10089 6045 2887
CRC, colorectal cancer; CSPY, colonoscopy; HRA, high-risk adenoma; LRA, low-risk adenoma; MLRA, multiple low-risk adenomas.